Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use ZORYVE cream safely and effectively. See full prescribing information for ZORYVE cream. ZORYVE® (roflumilast) cream 0.3% and 0.15%, for topical use Initial U.S. Approval: 2011
Medication labelWhy this: Advisory · dailymed-prescription
ZORYVE® cream, 0.3%, is indicated for topical treatment of plaque psoriasis, including intertriginous areas, in adult and pediatric patients 6 years of age and older. ZORYVE cream, 0.15%, is indicated for topical treatment of mild to moderate atopic dermatitis in adult and pediatric patients 6 years of age and older.
- generic_name
- roflumilast
- product_names
- roflumilast
- ndc
- 80610-130, 80610-130-60, 80610-130-05, 80610-130-96, 80610-115, 80610-115-60, 80610-115-05, 80610-115-96
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en